Stereoselective determination of R-(+)- and S-(-)-remoxipride, a dopamine D₂-receptor antagonist, in human plasma by chiral high-performance liquid chromatographyDEPUY, M. E; DEMETRIADES, J. L; MUSSON, D. G et al.Journal of chromatography. B, Biomedical sciences and applications. 1997, Vol 700, Num 1-2, pp 165-173, issn 1387-2273Article

Adverse effects of antipsychotic agents : Do newer agents offer advantages ?OWENS, D. G. C.Drugs (Basel). 1996, Vol 51, Num 6, pp 895-930, issn 0012-6667Article

Some practical findings for TA in organic and pharma industryWADSTEN, T.Journal of thermal analysis. 1996, Vol 47, Num 2, pp 525-533, issn 0368-4466Conference Paper

Separate measures of ethanol seeking and drinking in the rat: effects of remoxiprideCZACHOWSKI, Cristine L; SANTINI, Lindsay A; LEGG, Brooke H et al.Alcohol (Fayetteville, NY). 2002, Vol 28, Num 1, pp 39-46, issn 0741-8329, 8 p.Article

Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxiprideAWAD, A. G; LAPIERRE, Y. D; ANGUS, C et al.Journal of psychiatry & neuroscience. 1997, Vol 22, Num 4, pp 244-248, issn 1180-4882Article

Remoxipride : pharmacokinetics and effect on plasma prolactinMOVIN-OSSWALD, G; HAMMARLUND-UDENAES, M.British journal of clinical pharmacology. 1991, Vol 32, Num 3, pp 355-360, issn 0306-5251Article

Development of a new antipsychotic remoxipride, Monte Carlo, June 19-20, 1989SEDVALL, Göran.Acta psychiatrica scandinavica. Supplementum. 1990, Vol 82, Num 358, issn 0065-1591, 188 p.Conference Proceedings

Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activityLAURSEN, A. L; GERLACH, J.Acta psychiatrica Scandinavica. 1986, Vol 73, Num 1, pp 17-21, issn 0001-690XArticle

Remoxipride in the treatment of acute maniaCHOUINARD, G; STEINER, W.Biological psychiatry (1969). 1986, Vol 21, Num 14, pp 1429-1433, issn 0006-3223Article

Liquid chromatographic determination of a substituted benzamide in biological fluids using preconcentration and post-column extractionDE RUITER, C; BRINKMAN, U. A. T; FREI, R. W et al.Journal of liquid chromatography. 1987, Vol 10, Num 8-9, pp 1903-1916, issn 0148-3919Article

An open multicentre study of the treatment of florid schizophrenia with remoxiprideMCCREADIE, R. G; MORRISON, D; ECCLESTON, D et al.Acta psychiatrica Scandinavica. 1985, Vol 72, Num 2, pp 139-143, issn 0001-690XArticle

Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brainOGREN, S. O; HALL, H; KOHLER, C et al.European journal of pharmacology. 1984, Vol 102, Num 3-4, pp 459-474, issn 0014-2999Article

Effects of the atypical antipsychotic remoxipride on alcohol self-administrationFILES, F. J; DENNING, C. E; SAMSON, H. H et al.Pharmacology, biochemistry and behavior. 1998, Vol 59, Num 2, pp 281-285, issn 0091-3057Article

Remoxipride―a new potential antipsychotic drug: pharmacological effects and pharmacokinetics following repeated oral administration in male volunteersFARDE, L; GRIND, M; NILSSON, M.-I et al.Psychopharmacologia. 1988, Vol 95, Num 2, pp 157-161, issn 0033-3158Article

Critical dissolution tests of oral systems based on statistically designed experiments. II. In vitro optimization of screened variables on ER-coated spheres for the establishment of an in vitro/in vivo correlationABUZARUR-ALOUL, R; GJELLAN, K; SJÖLUND, M et al.Drug development and industrial pharmacy. 1998, Vol 24, Num 3, pp 203-212, issn 0363-9045Article

Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxiprideTRIMBLE, K. M; BELL, R; KING, D. J et al.Pharmacology, biochemistry and behavior. 1997, Vol 56, Num 4, pp 809-816, issn 0091-3057Article

Are there dissociable roles of the mesostriatal and mesolimbocortical dopamine systems on temporal information processing in humans?RAMMSAYER, T. H.Neuropsychobiology. 1997, Vol 35, Num 1, pp 36-45, issn 0302-282XArticle

Critical dissolution tests of oral systems based on statistically designed experiments. I. Screening of critical fluids and in vitro/in vivo modelling of extended release coated spheresABUZARUR-ALOUL, R; GJELLAN, K; SJÖLUND, M et al.Drug development and industrial pharmacy. 1997, Vol 23, Num 8, pp 749-760, issn 0363-9045Article

Potential of atypical antipsychotics in the treatment of nonpsychotic disordersPOTENZA, M. N; MCDOUGLE, C. J.CNS drugs. 1998, Vol 9, Num 3, pp 213-232, issn 1172-7047Article

Within-session behavioral decrement of atypical antipsychotics : Role of noveltyDE ANGELIS, L; FURLAN, C.Drug development research. 1997, Vol 42, Num 2, pp 71-75, issn 0272-4391Article

Psychomotor impairment and cognitive disturbances induced by neurolepticsKING, D. J.Acta psychiatrica scandinavica. Supplementum. 1994, Vol 89, Num 380, pp 53-58, issn 0065-1591Conference Paper

The tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophreniaKLIESER, E; STRAUSS, W. H; LEMMER, W et al.Acta psychiatrica scandinavica. Supplementum. 1994, Vol 89, Num 380, pp 68-73, issn 0065-1591Conference Paper

The pharmacokinetics of remoxipride and metabolites in patients with various degrees of renal functionMOVIN-OSSWALD, G; BOELAERT, J; HAMMARLUND-UDENAES, M et al.British journal of clinical pharmacology. 1993, Vol 35, Num 6, pp 615-622, issn 0306-5251Article

Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the ratSTAHLE, L; LJUNGBERG, T; RODEBJER, A et al.Pharmacology & toxicology. 1987, Vol 60, Num 3, pp 227-232, issn 0901-9928Article

Atypical neuroleptics : their contribution to the rehabilitation of schizophrenic patientsVANELLE, J. M; BROCHIER, T; BAYLE, F. J et al.European psychiatry. 1996, Vol 11, pp 85s-89s, issn 0924-9338, SUP2Conference Paper